Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Updated operating-status notice and added Bone osteosarcoma topic; removed old revision tag and added new revision tag v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T16:42:21.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-28T10:07:35.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:14:53.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-06T20:58:39.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, as well as the introduction of cabozantinib as a relevant drug. However, several key pieces of information related to Ewing sarcoma and other related topics have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:29:15.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.1%
    Check dated 2025-08-23T14:07:51.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.